Document is current
Any future updates will be listed below
-
Authors
Huq, Redwan
Samuel, Errol L. G.
Sikkema, William K. A.
Nilewski, Lizanne G.
Lee, Thomas
Tanner, Mark R.
Khan, Fatima S.
Porter, Paul C.
Tajhya, Rajeev B.
Patel, Rutvik S.
Inoue, Taeko
Pautler, Robia G.
Corry, David B.
Tour, James M.
Beeton, Christine
- License Information
-
More Information
Article History
Received: 15 July 2016
Accepted: 31 August 2016
First Online: 22 September 2016
Competing interests
: R.H., E.L.G.S., T.I., R.G.P., J.M.T. and C.B. are inventors on a patent application claiming PEG-HCCs as T lymphocyte immunomodulators for the treatment of inflammatory diseases. The patent rights are owned by Rice University and Baylor College of Medicine. These patents have been licensed to Acelerox, LLC in which J.M.T. owns stock. All potential conflicts of interest are managed through the respective institutional offices of research compliance. The other authors declare no competing financial interests.
